Canada - English - Health Canada

apotex inc - exemestane - tablet - 25mg - exemestane 25mg - antineoplastic agents

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

pfizer italia s.r.l. - exemestane - tablets coated - 25mg

Ireland - English - HPRA (Health Products Regulatory Authority)

originalis b.v. - exemestane - coated tablet - 25 milligram(s) - exemestane

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - exemestane 25 mg - coated tablet - 25 mg - exemestane 25 mg - exemestane

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pi pharma - exemestane - coated tablet - 25 mg - exemestane 25 mg - exemestane

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - exemestane 25 mg - film-coated tablet - 25 mg - exemestane 25 mg - exemestane

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - exemestane 25 mg - film-coated tablet - 25 mg - exemestane 25 mg - exemestane

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - exemestane 25 mg - film-coated tablet - 25 mg - exemestane 25 mg - exemestane

Israel - English - Ministry of Health

vitamed pharmaceutical industries ltd - exemestane - film coated tablets - exemestane 25 mg - exemestane - exemasin-vit is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone.exemasin-vit is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. exemasin-vit is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

Israel - English - Ministry of Health

devries & co. ltd - exemestane - film coated tablets - exemestane 25 mg - exemestane - treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breast cancer following 2-3 years of initial adjuvant tamoxifen therapy.